e-learning
resources
Munich 2014
Monday, 08.09.2014
Latest insights in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: The bitter tastants chloroquine and noscapine relax human bronchial smooth muscle by different effects on intracellular calcium signalling
M. Manson, A. James, J. Säfholm, S. E. Dahlén, M. Adner (Stockholm, Sweden)
Source:
International Congress 2014 – Latest insights in airway diseases
Session:
Latest insights in airway diseases
Session type:
Thematic Poster Session
Number:
2821
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Manson, A. James, J. Säfholm, S. E. Dahlén, M. Adner (Stockholm, Sweden). LATE-BREAKING ABSTRACT: The bitter tastants chloroquine and noscapine relax human bronchial smooth muscle by different effects on intracellular calcium signalling. Eur Respir J 2014; 44: Suppl. 58, 2821
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Bitter taste receptors are expressed and induce relaxation of human bronchi
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
Involvement of the BK channels/G proteins processes in the synergistic effects between anticholinergic agents and beta
2
-adrenoceptor agonists in airway smooth muscle
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013
Beneficial effects of menthol are mediated via a TRPM8-independent mechanism
Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD
Year: 2015
LATE-BREAKING ABSTRACT: The PDE4 inhibitor CHF-6001 and LAMAs cooperatively inhibit bronchoconstriction-induced remodeling in lung slices
Source: International Congress 2016 – Late-breaking topics in airways disease
Year: 2016
Prostacyclin IP receptor activation blocks hyperosmolar-induced bronchoconstriction in isolated human small airways
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016
Endothelin-1-mediated contraction of mouse small airways is resistant to salbutamol, but sensitive to rosiglitazone
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
Synergistic effects by combination of tiotropium with olodaterol result from cross talk between muscarinic and β2-adrenergic receptors via allosteric modulation
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016
Slow dissociation kinetics of LAMAs contribute to the functional interactions with LABAs
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016
Activation of TRPV4 causes bronchoconstriction: A possible role in respiratory disease?
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013
Allergen exposed primary human bronchial epithelial cells have inhibited transport of salbutamol sulphate only when functional organic cation tranporters are present
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014
Central role of AC6 in β2 agonist induced relaxation of human airway smooth muscle
Source: International Congress 2016 – Novel insights into the treatment of COPD
Year: 2016
Interaction between aclidinium bromide and formoterol fumarate; effects on human bronchial smooth muscle
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014
Bronchodilator activity of the combination of salbutamol hemisuccinate and methatropium iodide compared with monotherapy in preclinical studies
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
LATE-BREAKING ABSTRACT: Corticosteroid responsiveness in COPD
Source: International Congress 2016 – Novel strategies on COPD and asthma management
Year: 2016
Secretion of hyaluronic acid is mediated by muscarinic receptors in airway smooth muscle cells of patients with COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Pharmacological interaction between glycopyrronium bromide and indacaterol fumarate on the human airways tone
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016
Activation of TRPV4 triggers ATP release and mast cell dependent contraction of airway smooth muscle (ASM)
Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD
Year: 2015
The effect of adenosine on VEGF release from airway smooth muscle from subjects with asthma
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Abediterol has higher bronchodilatory potency than other long-acting beta
2
-receptor agonists in a guinea pig model
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014
IL33 and TNFalpha synergistically enhance store operated Ca
2+
entry in cultured human airway smooth muscle cells
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept